Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial

NCT04475159 is registered in ClinicalTrials.gov with Prof. Aviram Nissan as lead sponsor.

NCT NCT04475159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04475159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial
Lead sponsor
Prof. Aviram Nissan
Phase
Phase 2
Overall status
Unknown status
Start date
August 1, 2020
Completion date
August 1, 2023
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colon adenocarcinoma, metastatic colorectal cancer, peritoneal carcinomatosis